Here, we focus on PD and AADC deficiency, as these share aspects of their pathophysiologies; indeed, the studies on intraputaminal infusion of gene therapy against PD served as a basis for developing the therapy against AADC deficiency. The gene discussed is DDC; the disease is hyperinsulinemic hypoglycemia, familial, 4.